Diseases of the Nervous System, Phase II
Study of Safety and of the Mechanism of BLZ945 in ALS Patients
Volunteers
Health Professionals
What is the purpose of this trial?
This is an open label study to evaluate safety, tolerability and brain microglia response in participants with ALS following multiple doses of BLZ945.
- Trial withNovartis Pharmaceuticals
- Ages18 years - 75 years
- GenderBoth
Help Us Discover!
You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.
Principal Investigator
Sub-Investigators
- Last Updated07/23/2024
- Study HIC#2000026495